Hi,
Nobody mentioned the newest deal happened yesterday in US
10.8 B for a clinical-stage biotech is quite a lot of money, imo.
Well, it seems that very good times are coming, once the P2 results (positive) for NNZ2591 will be released
US10.8 bil would mean a price/share of US83 for Neuren (AU$124)
GLTA
Merck acquires Prometheus Biosciences in $10.8bn deal (biopharma-reporter.com)
Merck to acquire Prometheus in a US$ 10.8 b deal
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.79 |
Change
2.080(10.0%) |
Mkt cap ! $2.814B | |||
| Open | High | Low | Value | Volume |
| $23.00 | $23.07 | $21.60 | $11.30M | 504.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9 | $22.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.82 | 431 | 2 |
View Market Depth
| Last trade - 11.52am 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$22.78 |
Change
2.080 ( 10.1 %) |
||||
| Open | High | Low | Volume | ||
| $22.98 | $23.00 | $21.60 | 155402 | ||
| Last updated 12.10pm 27/05/2024 ? | |||||
| NEU (ASX) Chart |